Loxagen

Venture Round
loxagen.com Biotech & Healthcare Palo Alto, United States
Total Funding Undisclosed
Latest Round Undisclosed Venture Round
Last Announced Undisclosed
Investors 2 Backers
Decision Makers Profile Active

About Loxagen

Platform for Lipoxygenase Small Molecule Inhibitors. Lipoxygenases play a central role in driving pathways in cardiovascular and metabolic diseases. We translate deep mechanistic discoveries into innovative, IND-ready therapies.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters Palo Alto, United States
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website loxagen.com
Domain Registered Date Jun 22, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    loxagen.com

Investors & Backers

2
Berkeley SkyDeck
SkyDeck Berkeley

Funding History

1 Round
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

3

Kalidip Choudhury

CEO/Co-founder

Work email & phone locked Unlock →

Michael Holinstat

Scientific Founder

Work email & phone locked Unlock →

Theodore Holman

Scientific Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts